Personas / Equipo Humano

Jordi Antón López

Buscador de publicaciones

Publicaciones

  • Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva E, Panaviene V, Bader-Meunier B, Anton-Lopez J, Nielsen S, De Benedetti F, Kamphuis S, Stanevica V, Tracahana M, Ailioaie LM, Tsitsami E, Klein A, Minden K, Foeldvari I, Haas JP, Klotsche J, Horne AC, Consolaro A, Bovis F, Bagnasco F, Pistorio A, Martini A, Wulffraat N, Ruperto N and Paediatric Rheumatology International Trials Organisation (PRINTO), BiKeR and th.

    Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.

    ARTHRITIS RESEARCH & THERAPY . 20(1): 285-285. Nº de citas: 80

    [doi:10.1186/s13075-018-1780-z]

  • Marrani E, Foeldvari I, Anton-Lopez J, Cimaz R and Simonini G.

    Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach

    SEMINARS IN ARTHRITIS AND RHEUMATISM . 48(3): 495-503. Nº de citas: 18

    [doi:10.1016/j.semarthrit.2018.03.003]

  • Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat NM, Horneff G, Kasapcopur O, Schneider R, Anton-Lopez J, Barash J, Berner R, Corona F, Cuttica R, Fouillet-Desjonqueres M, Fischbach M, Foster HE, Foell D, Radominski SC, Ramanan AV, Trauzeddel R, Unsal E, Levy J, Vritzali E, Martini A and Lovell DJ.

    Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.

    ANNALS OF THE RHEUMATIC DISEASES . 77(12): 1710-1719. Nº de citas: 88

    [doi:10.1136/annrheumdis-2018-213150]

  • Ben-Chetrit E, Gattorno M, Gul A, Kastner DL, Lachmann HJ, Touitou I, Ruperto N and Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs.

    Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study

    ANNALS OF THE RHEUMATIC DISEASES . 77(11): 1558-1565. Nº de citas: 132

    [doi:10.1136/annrheumdis-2017-212515]

  • Ter Haar NM, van Delft ALJ, Annink KV, van Stel H, Al-Mayouf SM, Amaryan G, Anton-Lopez J, Barron KS, Benseler S, Brogan PA, Cantarini L, Cattalini M, Cochino AV, de Benedetti F, Dedeoglu F, de Jesus AA, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Kone-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Özen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Schulert G, Gattorno M and Frenkel J.

    In silico validation of the Autoinflammatory Disease Damage Index

    ANNALS OF THE RHEUMATIC DISEASES . 77(11): 1599-1605. Nº de citas: 28

    [doi:10.1136/annrheumdis-2018-213725]

  • Vanoni F, Caorsi R, Aeby S, Cochard M, Anton-Lopez J, Berg S, Brik R, Dolezalova P, Koné-Paut I, Neven B, Ozen S, Pillet P, Stojanov S, Wouters C, Gattorno M and Hofer M.

    Towards a new set of classification criteria for PFAPA syndrome

    Pediatric Rheumatology . 16: 60-60. Nº de citas: 39

    [doi:10.1186/s12969-018-0277-2]

  • Constantin T, Foeldvari I, Anton-Lopez J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Palinkas A, Pattani R, Gyorgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A and Ramanan AV.

    Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative

    ANNALS OF THE RHEUMATIC DISEASES . 77(8): 1107-1117. Nº de citas: 165

    [doi:10.1136/annrheumdis-2018-213131]

  • Arthur VL, Shuldiner E, Remmers EF, Hinks A, Grom AA, Foell D, Martini A, Gattorno M, Ozen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Oliveira S, Yeung RSM, Rosenberg AM, Wedderburn LR, Anton-Lopez J, Haas JP, Rosen-Wolff A, Minden K, Szymanski AM, Thomson W, Kastner DL, Woo P and Ombrello MJ.

    IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis.

    Arthritis & Rheumatology . 70(8): 1319-1330. Nº de citas: 44

    [doi:10.1002/art.40498]

  • Koné-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton-Lopez J and Piram M.

    The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series

    AUTOIMMUNITY REVIEWS . 17(8): 768-774. Nº de citas: 89

    [doi:10.1016/j.autrev.2018.01.024]

  • Girschick H, Finetti M, Orlando F, Schalm S, Insalaco A, Ganser G, Nielsen S, Herlin T, Kone-Paut I, Martino S, Cattalini M, Anton-Lopez J, Mohammed Al-Mayouf S, Hofer M, Quartier P, Boros C, Kuemmerle-Deschner J, Pires Marafon D, Alessio M, Schwarz T, Ruperto N, Martini A, Jansson A, Gattorno M and PRINTO and the Eurofever registry.

    The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry.

    RHEUMATOLOGY . 57(7): 1203-1211. Nº de citas: 140

    [doi:10.1093/rheumatology/key058]